Game developer and publisher Midway Games Inc. has recently licensed BioGraphic Technologies recently released AI.implant SDK for an action-adventure game in production for next generation platforms. AI.implant is a powerful real-time interactive commercial artificial intelligence animation solution that enables digital content creators to create rich AI character interactions. "We are extremely pleased to have Midway as a partner," said Dr. Paul Kruszewski, president and founder of BioGraphic Technologies. "Midway's adoption of AI.implant confirms our strategy of providing an AI game development solution that is well-balanced between strong creation tools for designers and a solid, well-supported SDK for developers. We are certain that many other top development studios will soon follow Midway's lead and put AI.implant to work to create better gameplay." BioGraphic Technologies is a Montreal, Canada-based provider of commercial artificial intelligence (AI) animation software. For more information about AI.implant, visit www.ai-implant.com.